about
Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63.Genome-wide identification of direct HBx genomic targetsReciprocal regulation of p63 by C/EBP delta in human keratinocytes.Interactions and CCAAT-binding of Arabidopsis thaliana NF-Y subunits.Regulation of the cyclin-dependent kinase inhibitor p57Kip2 expression by p63.p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2Genomic responses to hepatitis B virus (HBV) infection in primary human hepatocytes.The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells.Clinical relevance of the study of hepatitis B virus covalently closed circular DNA.Early inhibition of hepatocyte innate responses by hepatitis B virus.HBV cure: why, how, when?New p63 targets in keratinocytes identified by a genome-wide approach.Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.Novel targets for hepatitis B virus therapy.Development of hepatocellular carcinoma in chronic hepatitis B patients with advanced fibrosis is independent of viral genotype.Control of hepatitis B virus replication by innate response of HepaRG cells.Challenges to a Cure for HBV Infection.Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector.HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus.Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes.Liver capsule: Validated and potential novel targets to treat hepatitis B virus.Late hepatitis B reactivation following DAA-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.HCV core-mediated activation of latent TGF-β via thrombospondin drives the crosstalk between hepatocytes and stromal environment.The TFIID subunit TAF4 regulates keratinocyte proliferation and has cell-autonomous and non-cell-autonomous tumour suppressor activity in mouse epidermis.Kinetics of intrahepatic covalently closed circular DNA and serum hepatitis B surface antigen during antiviral therapy for chronic hepatitis B: lessons from experimental and clinical studies.Global strategies are required to cure and eliminate HBV infection.Mechanism of action of ribavirin in anti-HCV regimens: new insights for an age-old question?Identification of new p63 targets in human keratinocytes.[Analysis of intrahepatic virological events associated to chronic hepatitis B infection].Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo modelPredictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis BSerum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patientsCorrigendum to "Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis" [J Hepatol 71 (2019) 763-772]Hepatitis BBAY 41-4109-mediated aggregation of assembled and misassembled HBV capsids in cells revealed by electron microscopyBiological basis for functional cure of chronic hepatitis BToll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesisMechanisms of transcriptional repression of cell-cycle G2/M promoters by p63
P50
Q25256716-FE9A404C-06DA-42C7-93C3-06277E2034B1Q29048191-06656139-C0A9-4F16-92C9-53A574CD8148Q33300780-A4903CA7-92FA-4850-90BB-E44BD94C7EF4Q34389053-F80EBF83-9AD7-429C-8315-34ED6FC8719FQ34463904-21E63891-D3EC-4467-81C9-652A9888BA5DQ35042810-DA2A1488-AB0F-4D3A-9A97-C94B53281AA6Q35063436-A5E3FFF5-440C-4E8C-86B9-9EBE50CE76B6Q36689117-FACA76DD-4B9D-4AE3-A087-56EFC20177C6Q37211959-6422247A-3444-4E03-97CD-3D7F731C0E30Q38685587-B954A0C1-2E98-4EE1-87DE-8F85C732C385Q38848763-5784B04E-63C6-446E-98F1-901B3945EE5CQ38905469-364A8C49-18F3-457E-A2CE-0443341D5596Q38977591-141B62AF-7C79-4793-9EC0-0663B6598609Q39043903-FEFE84E6-F5BE-40EA-BBFC-9626487D26EEQ39067316-122C33E2-5C7A-4E7F-B098-3C8497F52117Q39317538-346C3FDD-5CEC-4E6F-915B-1718DE373515Q39781596-9BB8FBE2-94E5-4D01-82AD-C1D34CC220EAQ40077687-52900688-22F0-4D21-B427-35939A5600DEQ40122305-B6163259-E23D-4511-AFD8-64E3AFECAA3AQ40490464-9A847432-4599-4A07-9CD0-D4BF95B11183Q40757777-A9687693-3F59-4114-AF77-D814959DAC94Q41156164-08C81210-A287-468C-8C12-EE7FEA3E8C13Q41412118-17C7B706-2FC9-4344-9867-4F48A3034863Q41935501-484B44D7-57D0-4745-8BAC-66A43136410BQ42278042-F6334B7E-A8FA-4EC3-9CF6-57467612BEB0Q42515756-03B4E61A-13F2-4F90-A7B9-865EA6D3E289Q44736020-6E742F64-1C98-4DBC-BF99-BE4EA7674A2DQ48860247-BEB57D0A-8824-4F36-83E2-20EF3906BFBBQ50548636-E4701026-6D51-4611-89DB-256514C3C3EFQ51582639-C07C058C-9BC9-4767-89C0-5C4764F60CC6Q52920631-D21E296C-63AD-42E7-AAA4-1AA3D5F84C9BQ57132035-9CB0E5E1-4C18-4CDE-BA4A-0AA74C75624BQ90342082-F2A11F4C-F44D-43B8-8421-9EB332FDE44AQ90358473-A4AA052B-4E95-477C-867B-0CD62F6FB8D3Q91521304-1E1F9B72-8E67-48E9-BAB1-571E46463B4AQ91598954-C8692906-99E9-46F0-B027-3939DFE0A301Q91852917-03DE5C94-3705-4944-955C-DF915D513E50Q91896445-4A218A9B-507A-47AA-8713-30B3690E91BCQ92906132-6FE05BC4-3A17-4B19-A51D-90CA6DA672F2Q94028817-E43E5A74-45E0-4044-BC2F-F18D35251932
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Barbara Testoni
@ast
Barbara Testoni
@en
Barbara Testoni
@es
Barbara Testoni
@nl
Barbara Testoni
@sl
type
label
Barbara Testoni
@ast
Barbara Testoni
@en
Barbara Testoni
@es
Barbara Testoni
@nl
Barbara Testoni
@sl
prefLabel
Barbara Testoni
@ast
Barbara Testoni
@en
Barbara Testoni
@es
Barbara Testoni
@nl
Barbara Testoni
@sl
P1053
F-3767-2017
P106
P21
P31
P3829
P496
0000-0001-5588-5465